Q&A with National Health Council: Driving Patient-Centred Policy

Why It Matters

Embedding patient voices directly into pricing negotiations and care design safeguards access while creating a strategic advantage for organizations that adopt structured engagement, reshaping industry standards for value‑based health delivery.

Key Takeaways

• NHC leads patient input in IRA drug price negotiations
• IPAY process now includes mandatory patient voice per NHC advocacy
• 2026 Summit opens to broader health sector audience
• Tools like Compensation Toolbox help embed patient engagement
• Patient engagement shifted from optional to business‑critical function

Pulse Analysis

The National Health Council, founded in 1920, has become the de‑facto hub for patient‑centered advocacy across the U.S. health ecosystem. By convening insurers, pharma, device makers, and patient groups, the council ensures that the patient voice shapes everything from drug development to reimbursement policy. Its recent success in embedding patient input into the Inflation Reduction Act’s Initial Price Applicability Year negotiations illustrates how a coordinated civil‑society effort can influence federal pricing frameworks and protect access to affordable therapies. This collaborative model is increasingly viewed as essential for sustainable healthcare innovation.

NHC’s digital toolbox translates that advocacy into actionable resources for members and the broader health community. The Patient Engagement Compensation and Contracting Toolbox, a Rubric to Capture the Patient Voice, and detailed guides on the IPAY process give organizations concrete methods to integrate patient perspectives into contracts, clinical trial design, and value‑based payment models. Early adopters report faster study enrollment, more relevant endpoints, and stronger payer negotiations, demonstrating that structured engagement not only satisfies regulatory expectations but also drives commercial advantage. Such integration also aligns with emerging ESG criteria for health investors.

The 2026 Science of Patient Engagement Summit, held May 11‑12 in Arlington, VA, marks the council’s ninth edition and its first open‑to‑all format. By inviting a wider health‑sector audience, the event aims to showcase real‑world case studies, share best‑practice toolkits, and spark cross‑industry collaborations that embed patient insight into research, care delivery, and policy formulation. Attendees can expect actionable takeaways that accelerate the shift from treating patient engagement as a compliance checkbox to leveraging it as a strategic growth engine for the entire health ecosystem. The summit’s outcomes are expected to influence upcoming CMS guidance on patient‑centric metrics.